Veeva Systems Inc. 为北美、欧洲、亚太、中东、非洲和拉丁美洲的生命科学行业提供基于云的软件。公司总部位于加利福尼亚州普莱森顿。
财务指标
营业收入
2026-07-31
$9.27亿
2026-04-30
$8.82亿
2026-01-31
$8.35亿
2025-10-31
$8.11亿
营业支出
2026-07-31
$4.2亿
2026-04-30
$3.88亿
2026-01-31
$3.76亿
2025-10-31
$3.7亿
净利润
2026-07-31
$2.73亿
2026-04-30
$2.6亿
2026-01-31
$2.44亿
2025-10-31
$2.36亿
净利润率
2026-07-31
29.46%
2026-04-30
29.55%
2026-01-31
29.21%
2025-10-31
29.11%
每股收益
2026-07-31
$1.68
2026-04-30
$2.24
2026-01-31
$2.06
2025-10-31
$2.04
息税折旧摊销前利润
2026-07-31
$3.6亿
2026-04-30
$2.84亿
2026-01-31
$3.28亿
2025-10-31
$3.22亿
有效税率
2026-07-31
21.77%
2026-04-30
24.91%
2026-01-31
23.09%
2025-10-31
24.48%
项目
2026-07-31
2026-04-30
2026-01-31
2025-10-31
营业收入
$9.27亿
$8.82亿
$8.35亿
$8.11亿
营业支出
$4.2亿
$3.88亿
$3.76亿
$3.7亿
净利润
$2.73亿
$2.6亿
$2.44亿
$2.36亿
净利润率
29.46%
29.55%
29.21%
29.11%
每股收益
$1.68
$2.24
$2.06
$2.04
息税折旧摊销前利润
$3.6亿
$2.84亿
$3.28亿
$3.22亿
有效税率
21.77%
24.91%
23.09%
24.48%
常见问题
VEEV represents Veeva Systems, a cloud software provider focused on the global life sciences industry. Its products support clinical trials, regulatory submissions, quality management, and commercial operations for pharmaceutical and biotechnology companies. Veeva also offers CRM tools tailored to life sciences and expanding solutions in areas such as medical devices and consumer goods. The company generates revenue primarily through subscription services, which gives it a recurring revenue model that many investors monitor.
Recent performance for VEEV depends on current market conditions and company-specific news, so the exact price change is best confirmed using the latest quote and chart on this page. Investors can review the displayed daily, weekly, and year-to-date moves to see how the stock has trended. Performance may also be compared with relevant software or healthcare technology benchmarks to provide context.
Evaluating VEEV's valuation typically involves comparing its price to measures such as earnings, sales, and cash flow, along with growth expectations. Because software companies often reinvest heavily, metrics like price-to-sales or enterprise value-to-revenue can be useful alongside the P/E ratio. It is also helpful to compare VEEV against similar cloud or healthcare technology companies and to consider whether the current valuation reflects its growth and profitability outlook.
Trading outside regular U.S. market hours may be possible through certain brokers that offer pre-market and after-hours sessions. These sessions can have lower liquidity, wider spreads, and higher volatility than the standard trading day. Whether VEEV is available for extended-hours trading depends on the specific brokerage and venue, so investors should check with their platform for availability and any associated risks.
VEEV is a listed U.S. stock and generally sees meaningful daily trading volume, though activity can vary with market conditions and news. Higher liquidity usually means tighter bid-ask spreads and easier execution for typical orders, while volume spikes may occur around earnings or major announcements. The latest volume and average volume figures on this page can provide a clearer, up-to-date picture of trading activity.
Veeva Systems has historically not paid a regular cash dividend, instead retaining earnings to fund growth and reinvestment in its business. Dividend policies can change over time, so investors should verify the latest status through VEEV's official investor relations materials or the dividend information displayed on this page. For income-focused investors, that distinction matters when comparing VEEV with dividend-paying software or healthcare companies.